← FDA DRUG APPROVALS

FDA NDA · NDA020180

PROSCAR

finasteride

Sponsor: ORGANON

APPLICATION
NDA020180
TYPE
NDA
ORIGINAL APPROVAL
1992-06-19
LATEST ACTION
2026-03-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

PROSCAR · ReferencePrescription
FINASTERIDE 5MG · TABLET · ORAL

Approval history

2026-03-18Labeling · Supplement 50 · standardLetterAP
2021-08-25Labeling · Supplement 49 · standardLetterAP
2021-06-15Labeling · Supplement 47 · standardLetterAP
2021-04-13Labeling · Supplement 48 · standardLetterAP
2015-07-06Manufacturing (CMC) · Supplement 45 · priorityAP
2014-03-11Labeling · Supplement 44 · standardLabelAP
2013-01-16Labeling · Supplement 43 · unknownLetterAP
2012-04-11Labeling · Supplement 41 · unknownLabelAP
2012-04-11Labeling · Supplement 42 · unknownLetterAP
2012-04-11Labeling · Supplement 40 · unknownLetterAP
2011-06-10Labeling · Supplement 35 · unknownLetterAP
2011-06-09Labeling · Supplement 39 · unknownLetterAP
2010-10-04Labeling · Supplement 37 · unknownLabelAP
2010-03-23Labeling · Supplement 33 · unknownLetterAP
2004-04-23Labeling · Supplement 29 · standardReviewAP
2004-04-12Efficacy · Supplement 26 · unknownReviewAP
2003-09-23Labeling · Supplement 20 · standardReviewAP
2003-09-09Labeling · Supplement 27 · standardReviewAP
2003-06-26Labeling · Supplement 25 · standardReviewAP
2002-11-26Manufacturing (CMC) · Supplement 24 · priorityReviewAP
2002-10-28Manufacturing (CMC) · Supplement 23 · priorityReviewAP
2001-01-30Labeling · Supplement 22 · standardReviewAP
2001-01-17Labeling · Supplement 19 · standardReviewAP
1999-08-02Labeling · Supplement 18 · standardReviewAP
1998-03-20Efficacy · Supplement 15 · standardReviewAP
1998-03-20Efficacy · Supplement 16 · priorityReviewAP
1997-12-19Labeling · Supplement 17 · standardReviewAP
1997-05-16Manufacturing (CMC) · Supplement 14 · priorityReviewAP
1997-05-12Manufacturing (CMC) · Supplement 13 · priorityReviewAP
1996-08-28Labeling · Supplement 11 · standardReviewAP
1996-07-24Manufacturing (CMC) · Supplement 10 · priorityReviewAP
1994-12-30Labeling · Supplement 9 · standardAP
1994-05-18Labeling · Supplement 7 · standardAP
1994-05-18Labeling · Supplement 8 · standardAP
1993-09-16Manufacturing (CMC) · Supplement 6 · priorityAP
1993-09-01Manufacturing (CMC) · Supplement 5 · priorityAP
1993-04-05Manufacturing (CMC) · Supplement 4 · priorityAP
1992-12-22Manufacturing (CMC) · Supplement 2 · priorityAP
1992-12-22Labeling · Supplement 3 · standardAP
1992-08-20Labeling · Supplement 1AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →